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Chikungunya virus (CHIKV) has been responsible for a
massive outbreak in the Indian Ocean region in 2005–
2006. CHIKV typically induces a benign disease character-
ized by fever, arthralgia, myalgia and rash. Severe cases
with CHIKV-associated central nervous system (CNS)
symptoms have also recently been described, notably in
neonates. We have developed animal models for the mild
and severe forms of the disease. Wild type (WT) mouse
neonates are susceptible to CHIKV infection following
intradermal inoculation, and neonatal disease severity is
age-dependent. In contrast to WT adult mice, those with a
partially abrogated type-I IFN pathway (IFN-α/βR+/- mice)
develop a mild disease closely mimicking benign human
Chikungunya disease. In contrast, adult mice with a
totally abrogated type-I IFN pathway (IFN-α/βR-/- mice)
develop a severe and lethal infection. In these mouse
models, infection leads to viremia and CHIKV is recov-
ered in fibroblasts from muscles, joints and skin. This cell
and tissue tropism is consistent with symptoms in
infected humans and confirmed by observations in
patients biopsy samples. In adult IFN-α/βR-/- mice as well
as in neonates, CHIKV infection causes a severe disease
associated with high viral load in serum and peripheral
tissues and dissemination to the CNS. CHIKV is not
detected at the brain microvessels and parenchyma, but
found in choroid plexus, ependymal and meningeal cells.
In agreement with these findings, CHIKV is detected in the
CSF in human patients with severe human Chikungunya
disease associated with CNS symptoms. Thus, in contrast
to what is observed for American encephalitic alphavi-
ruses, CHIKV does not appear to be genuinely encepha-
litogenic and is associated with reversible CNS symptoms
in man. This is in line with a virus that does not invade the
brain parenchyma nor infect neurons. Leptomeningeal
cells are, as fibroblasts, of mesenchymal origin and
exhibit features similar to those of peripheral fibroblastic
connective tissue capsules. Leptomeningeal cells also play
an "envelope" function and form an interconnected mul-
ticellular network that acts as a regulatory interface
between cerebrospinal fluid and the surface of the brain as
well as between arterioles of the Virchow-Robin spaces
and the surrounding brain tissue. These observations will
be instrumental to understand the short- and long-term
consequences of the infection of brain envelopes.
from Infectious diseases of the nervous system: pathogenesis and worldwide impact
Paris, France. 10–13 September 2008
Published: 23 September 2008
BMC Proceedings 2008, 2(Suppl 1):S7
<supplement> <title> <p>Infectious diseases of the nervous system: pathogenesis and worldwide impact</p> </title> <editor>Roberto Bruzzone, Monique Dubois-Dalcq, Georges E Grau, Diane E Griffin and Krister Kristensson</editor> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1753-6561-2-S1-full.pdf">here</a>.</note> </supplement>
This abstract is available from: http://www.biomedcentral.com/1753-6561/2/S1/S7
© 2008 Couderc et al; licensee BioMed Central Ltd. 
